Inhibition of ligand-gated cation-selective channels by tamoxifen. 1998

M C Allen, and C Newland, and M A Valverde, and S P Hardy
Department of Pharmacy, University of Brighton, UK.

The nonsteroidal antioestrogen tamoxifen has been shown to block a number of voltage-gated cation-selective channels but its effect on ligand-gated cation-selective channels has not been studied. We have investigated the action of tamoxifen and the related derivative toremifene on ligand-gated cationic nicotinic acetylcholine and 5-HT3 receptor channels. Tamoxifen and toremifene both inhibited cationic currents of adult-type human muscle nicotinic acetylcholine receptors expressed in Xenopus oocytes with similar IC50 values of 1.2 +/- 0.03 microM (nH = 0.84 +/- 0.02) and 1.2 +/- 0.1 microM (nH = 1.1 +/- 0.1), respectively. Tamoxifen could also block native 5-HT3 receptors in NG108-15 neuroblastoma/glioma hybrid cells with IC50 = 0.81 +/- 0.15 microM and nH of 1.3 +/- 0.3. The characteristics of block by tamoxifen at the 5-HT3 receptor were voltage- and use-independent. The inhibition of the 5-HT-evoked currents were not overcome by increasing concentrations of 5-HT consistent with a noncompetitive mechanism of block.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D011985 Receptors, Serotonin Cell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action. 5-HT Receptor,5-HT Receptors,5-Hydroxytryptamine Receptor,5-Hydroxytryptamine Receptors,Receptors, Tryptamine,Serotonin Receptor,Serotonin Receptors,Tryptamine Receptor,Tryptamine Receptors,Receptors, 5-HT,Receptors, 5-Hydroxytryptamine,5 HT Receptor,5 HT Receptors,5 Hydroxytryptamine Receptor,5 Hydroxytryptamine Receptors,Receptor, 5-HT,Receptor, 5-Hydroxytryptamine,Receptor, Serotonin,Receptor, Tryptamine,Receptors, 5 HT,Receptors, 5 Hydroxytryptamine
D004965 Estrogen Antagonists Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. Estradiol Antagonists,Antagonists, Estradiol,Antagonists, Estrogen
D006825 Hybridomas Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure MONOCLONAL ANTIBODIES or T-cell products, identical to those produced by the immunologically competent parent cell. Hybridoma
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013629 Tamoxifen One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. ICI-46,474,ICI-46474,ICI-47699,Nolvadex,Novaldex,Soltamox,Tamoxifen Citrate,Tomaxithen,Zitazonium,Citrate, Tamoxifen,ICI 46,474,ICI 46474,ICI 47699,ICI46,474,ICI46474,ICI47699
D015640 Ion Channel Gating The opening and closing of ion channels due to a stimulus. The stimulus can be a change in membrane potential (voltage-gated), drugs or chemical transmitters (ligand-gated), or a mechanical deformation. Gating is thought to involve conformational changes of the ion channel which alters selective permeability. Gating, Ion Channel,Gatings, Ion Channel,Ion Channel Gatings
D044406 Receptors, Serotonin, 5-HT3 A subclass of serotonin receptors that form cation channels and mediate signal transduction by depolarizing the cell membrane. The cation channels are formed from 5 receptor subunits. When stimulated the receptors allow the selective passage of SODIUM; POTASSIUM; and CALCIUM. Serotonin 3 Receptor,5-HT3 Receptor,5-Hydroxytryptamine-3 Receptor,Receptor, Serotonin 3,Receptor, Serotonin, 5-HT3 Subunit A,Receptor, Serotonin, 5-HT3 Subunit B,Receptor, Serotonin, 5-HT3 Subunit C,Receptor, Serotonin, 5-HT3 Subunit D,Receptor, Serotonin, 5-HT3 Subunit E,Receptor, Serotonin, 5-HT3A,Receptor, Serotonin, 5-HT3B,Receptor, Serotonin, 5-HT3C,Receptor, Serotonin, 5-HT3D,Receptor, Serotonin, 5-HT3E,Serotonin 3 Receptors,5 HT3 Receptor,5 Hydroxytryptamine 3 Receptor,Receptor, 5-Hydroxytryptamine-3,Receptors, Serotonin 3
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

M C Allen, and C Newland, and M A Valverde, and S P Hardy
July 2000, Journal of the autonomic nervous system,
M C Allen, and C Newland, and M A Valverde, and S P Hardy
January 1991, Annals of the New York Academy of Sciences,
M C Allen, and C Newland, and M A Valverde, and S P Hardy
August 1992, Current opinion in cell biology,
M C Allen, and C Newland, and M A Valverde, and S P Hardy
July 2000, Nature,
M C Allen, and C Newland, and M A Valverde, and S P Hardy
April 1999, Annals of the New York Academy of Sciences,
M C Allen, and C Newland, and M A Valverde, and S P Hardy
May 2019, Nanoscale,
M C Allen, and C Newland, and M A Valverde, and S P Hardy
March 2005, IEEE transactions on nanobioscience,
M C Allen, and C Newland, and M A Valverde, and S P Hardy
May 2009, Journal of visualized experiments : JoVE,
M C Allen, and C Newland, and M A Valverde, and S P Hardy
January 2009, Neuropharmacology,
M C Allen, and C Newland, and M A Valverde, and S P Hardy
March 2009, Neuropharmacology,
Copied contents to your clipboard!